PubMed COVID-19 Clinical Care

BACKGROUND: Data on antibody response following COVID-19 in kidney transplant recipients is scarce. This crosssectional study aims to investigate the antibody response to COVID-19 among kidney transplant recipients.

The effectiveness and political feasibility of COVID-19 containment measures such as lockdowns, are contentious. This stems in part from an absence of tools for their rigorous evaluation. Common epidemiological models such as the SEIR model generally

INTRODUCTION: Multiple sclerosis (MS) is an immune-mediated disorder of the CNS manifested by recurrent attacks of neurological symptoms (related to focal inflammation) and gradual disability accrual (related to progressive neurodegeneration and

Brazil was one of the countries most impacted by the COVID-19 pandemic, with a cumulative total of nearly 700,000 deaths by early 2023. The country's federative units were unevenly affected by the pandemic and adopted mitigation measures of different

Multiple studies of vaccinated and convalescent cohorts have demonstrated that serum neutralizing antibody (nAb) titers correlate with protection against coronavirus disease 2019 (COVID-19). However, the induction of multiple layers of immunity after

The COVID-19 pandemic has caused substantial population infections worldwide. COVID-19 has been reported to cause acute epiglottitis (AE); nonetheless, COVID-19-related AE is poorly understood by healthcare workers because of the disease's low

We report a case of COVID-19-associated meningoencephalitis with a fatal outcome in a male patient with concomitant influenza A, who had been hospitalized at the beginning of 2022, in the Northeastern region of Brazil. He died due to cardiopulmonary

No abstract

Objectives: In this study, we aimed to clarify and measure the interrelationships among decrease in communication, exercise, and physical and mental health under COVID-19 prevention measures, restricting individuals from going out of the house

CONCLUSIONS: The LIIP is a safe and effective CIIP in managing intravenous insulin infusion rates. Utilization of LIIP resulted in reduced time to euglycemia, P .001, when compared with Glucommander and did not cause increased hypoglycemia during